APA (7th ed.) Citation

Le Roux, C. W., Wharton, S., Bozkurt, B., Platz, E., Bleckert, G., Ajaz Hussain, S., . . . Kaplan, L. M. (2025). Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE-1). Diabetes, obesity and metabolism. https://doi.org/10.1111/dom.70196

Chicago Style (17th ed.) Citation

Le Roux, Carel W., et al. "Survodutide for Treatment of Obesity: Baseline Characteristics of Participants in a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial (SYNCHRONIZE-1)." Diabetes, Obesity and Metabolism 2025. https://doi.org/10.1111/dom.70196.

MLA (9th ed.) Citation

Le Roux, Carel W., et al. "Survodutide for Treatment of Obesity: Baseline Characteristics of Participants in a Randomized, Double-blind, Placebo-controlled, Phase 3 Trial (SYNCHRONIZE-1)." Diabetes, Obesity and Metabolism, 2025, https://doi.org/10.1111/dom.70196.